Jwc ewma final indd

122Nyborg,W.L.Ultrasonic

microstreamingandrelated

phenomena.BrJCancer.1982;45:

156–160.

123Johns,L.D.Nonthermaleffects

ofherapeuticultrasoundthe

frequencyresonancehypothesis.J

AthlTrain.2002;37:293–299.

124Ennis,W.J.,Valdes,W.,Gainer,

M.,Meneses,P.Evaluationofclinical

effectivenessofMISTultrasound

therapyforthehealingofchronic

wounds.AdvSkinWoundCare.

2006;19:437–446.

125Ramundo,J.,Gray,M.Is

ultrasonicmisttherapyeffectivefor

debridingchronicwounds?JWound

OstomyContinenceNurs.2008;

35:579–583.

126Lebrun,E.,Tomic-Canic,M.,

Kirsner,R.S.Theroleofsurgical

debridementinhealingofdiabetic

footulcers.WoundRepairRegen.

2010;18:433–438.

127Brigido,S.A.Theuseofan

cellulardermalregenerativetissue

matrixinthetreatmentoflower

extremitywounds:aprospective

16-weekpilotstudy.IntWoundJ.

2006;3:181–187.

128Zeitani,J.,Bertoldo,F.,

Bassano,C.etal.Superficialwound

dehiscenceaftermediansternotomy:

surgicaltreatmentversussecondary

woundhealing.AnnThoracicSurg.

2004;77:672–675.

129Al-Arabi,Y.B.,Nader,M.,

Hamidian-Jahromi,A.R.,Woods,D.A.

Theeffectofthetimingofantibiotics

andsurgicaltreatmentoninfection

ratesinopenlong-bonefractures:

A9-yearprospectivestudyfroma

districtgeneralhospital.Injury.2007;

38:900–905.

130Haycocks,S.,Chadwick,P.

Sharpdebridementofdiabetic

footulcersandtheimportance

ofmeaningfulinformedconsent.

WoundsUK.2008;4:51–56.

131Cardinal,M.,Eisenbud,D.E.,

Armstrong,D.G.etal.Serialsurgical

debridement:Aretrospectivestudy

onclinicaloutcomesinchronic

lowerextremitywounds.Wound

RepairRegen.2009;17:306–311.

132Williams,D.,Enoch,S.,Miller,D.

etal.Effectofsharpdebridement

usingcuretteonrecalcitrant

nonhealingvenouslegulcers:A

concurrentlycontrolled,prospective

cohortstudy.WoundRepairRegen.

2005;13:131–137.

133Steed,D.L.,Attinger,C.,Brem,H.

etal.Guidelinesfortheprevention

ofdiabeticulcers.WoundRepair

Regen.1996;16:169–174.

134Lewis,R.,Whiting,P.,terRiet,G.

etal.Arapidandsystematicreview

oftheclinicaleffectivenessandcost-

effectivenessofdebridingagentsin

treatingsurgicalwoundshealingby

secondaryintention.HealthTechnol

Assess.2001;5:14,1–131.

135RagnarsonTennvall,G.,Apelqvist,

J.,Eneroth,M.Costsofdeepfoot

infectionsinpatientswithdiabetes

mellitus.Pharmacoeconomics.2000;

18:225–238.

136RagnarsonTennvall,G.,Apelqvist,

J.Health-economicconsequencesof

diabeticfootlesions.ClinInfectDis.

2004;39(Suppl.2):S132–139.

137Apelqvist,J.,Ragnarson

Tennvall,G.,Persson,U.etal.

Diabeticfootulcersinamulti-

disciplinarysetting.Aneconomic

analysisofprimaryhealingand

healingwithamputation.JIntMed.

1994;235:463–471.

138Prompers,L.,Huijberts,M.,

Apelqvist,J.etal.Highprevalence

ofischaemia,infectionandserious

comorbidityinpatientswithdiabetic

footdiseaseinEurope.Baseline

resultsfromtheEURODIALEstudy.

Diabetologia.2007;50:18–25.

139Prompers,L.,Huijberts,M.S.P.,

Schaper,N.C.etal.Resource

utilisationandcostsassociated

withthetreatmentofdiabeticfoot

ulcers.Prospectivedatafromthe

EurodialeStudy,Diabetologia.2008;

51:1826–1834.

140Ballard-Krishnan,S.,vanRijswijk,

L.,Polansky,M.Pressureulcersin

extendedcarefacilities:report

ofasurvey.JWoundOstomy

ContinenceNurs.1994;21:4–11.

141Olin,J.W.,Beusterien,K.M.,

Childs,M.B.etal.Medicalcosts

oftreatingvenousstasisulcers:

evidencefromaretrospective

cohortstudy.VascMed.1999;4:1–7.

142Kerstein,M.D.,Gemmen,E.,

vanRijswijk,L.etal.Costandcost

effectivenessofvenousandpressure

ulcerprotocolsofcare.DisManage

HealthOutcomes.2005;9:651–663.

143Posnett,J.,Gottrup,F.,

Lundgren,H.,Saal,G.Theresource

impactofwoundsonhealth-care

providersinEurope.JWoundCare.

2009;18:154–161.

144Boulton,A.J.M.,Vileikyte,L.,

RagnarsonTennvall,G.,Apelqvist,J.

Theglobalburdenofthediabeticfoot

disease.Lancet.2005;336:1719–1724.

145Persson,U.,Willis,M.,Ödegaard,

K.,Apelqvist,J.Thecost-effectiveness

oftreatingdiabeticlowerextremity

ulcerswithbecaplermin(Regranex).

Acaremodelwithanapplication

usingSwedishcostdata.Value

Health.2000;3(Suppl.1):39–46.

146Margolis,D.J.,Gross,E.A.,Wood,

C.R.,Lazarus,G.S.Planimetricrateof

healinginvenousulcersoftheleg

treatedwithpressurebandageand

hydrocolloiddressing.JAmAcad

Dermatol.1993;28:418–421.

147Falanga,V.,Saap,L.J.,Ozonoff,A.

Woundbedscoreanditscorrelation

withhealingofchronicwounds.

DermatolTher.2006;19:383–390.

148RagnarsonTennvall,G.,

Hjelmgren,J.Annualcostsof

treatmentforvenouslegulcersin

SwedenandtheUnitedKingdom.

WoundRepairRegen.2005;13:

13–18.

149Gottrup,F.,Appelqvist,J.,Price,

P.Outcomesincontrolledand

comparativestudiesonnon-healing

wounds:Recommendationsto

improvethequalityofevidence

inwoundmanagement.JWound

Care.2010;19:237–268.

150Posnett,J.,Franks,P.J.Thecosts

ofskinbreakdownandulceration

intheUK.In:Pownall,M.(ed).Skin

Breakdown—TheSilentEpidemic.

Smith&NephewFoundation,2010.

151Oien,R.F.,RagnarsonTennvall,

G.Accuratediagnosisandeffective

treatmentoflegulcersreduce

prevalence,caretimeandcosts.J

WoundCare.2006;15:259–262.

152Drummond,M.F.,Schulpher,

M.J.,Torrance,G.W.etal.Methods

fortheeconomicevaluationof

healthcareprogrammes(3rdedn).

OxfordUniversityPress,2005.

153Granick,M.,Boykin,J.,Gamelli,

R.etal.Towardacommonlanguage:

surgicalwoundbedpreparation

anddebridement.WoundRepair

Regen.2005;14(Suppl.1):1–10.

154Mosti,G.,Iabichella,M.L.,Picerni,

P.etal.Thedebridementofhardto

heallegulcersbymeansofanew

devicebasedonFluidjettechnology.

IntWoundJ.2005;2:307–314.

155Mulder,G.D.Cost-effective

managedcare:gelversuswet-

to-dryfordebridement.Ostomy

WoundManage.1995;41:2,68–74.

---

S 4 6